Medicare Enrolled

Dr. Dana Chase, M.D.

Gynecologic Oncology Physician · Los Angeles, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
200 UCLA MEDICAL PLZ STE 220, Los Angeles, CA 90095
3107947274
In practice since 2007 (19 years)
NPI: 1396888947 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chase from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chase? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chase

Dr. Dana Chase is a gynecologic oncology physician in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Chase performed 93 Medicare services across 77 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chase received a total of $1,226,552 from 47 pharmaceutical and/or device companies across 969 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gynecologic oncology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chase is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 93 Medicare services $1,226,552 industry payments

Medicare Practice Summary

Medicare Utilization ↗
93
Medicare services
Bottom 17% in CA for gynecologic oncology physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
77
Unique beneficiaries
$125
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~5 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
40 $103 $858
New patient office visit, complex (60-74 min) 23 $179 $1,360
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
16 $147 $960
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
14 $74 $508
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,226,552
Total received (2018-2024)
Avg $175,222/year across 7 years
Top 0% in CA for gynecologic oncology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
969
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,115,245 (90.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$106,293 (8.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,014 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$213,005
2023
$249,474
2022
$178,671
2021
$100,132
2020
$102,430
2019
$287,402
2018
$95,439

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$105,604
AstraZeneca Pharmaceuticals LP
$35,492
ABBVIE INC.
$30,182
Genmab U.S., Inc.
$15,835
Eisai Inc.
$12,795
PFIZER INC.
$7,677
Karyopharm Therapeutics Inc.
$4,211
Myriad Genetic Laboratories, Inc.
$1,000
Pacira Pharmaceuticals Incorporated
$128
Merck Sharp & Dohme LLC
$64
Baxter Healthcare
$18
Top 3 companies account for 80.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$464,950
GlaxoSmithKline, LLC.
$273,765
TESARO, Inc.
$63,766
Genmab U.S., Inc.
$60,356
Clovis Oncology, Inc.
$54,116
Seagen Inc.
$53,015
Eisai Inc.
$50,610
Genentech USA, Inc.
$35,846
ABBVIE INC.
$30,205
Merck Sharp & Dohme Corporation
$20,758
Merck Sharp & Dohme LLC
$19,353
Intuitive Surgical, Inc.
$12,431
ImmunoGen, Inc.
$10,558
Baxter Healthcare
$9,309
EISAI INC.
$9,170
PFIZER INC.
$7,705
BAXTER HEALTHCARE
$7,609
Takeda Pharmaceutical Company, Limited
$6,617
Myriad Genetic Laboratories, Inc.
$6,158
Karyopharm Therapeutics Inc.
$6,085
Pharmacosmos Therapeutics Inc.
$4,585
Heron Therapeutics, Inc.
$4,481
Takeda Pharmaceuticals International, Inc.
$4,200
AstraZeneca UK Limited
$2,598
Dova Pharmaceuticals
$2,500
Takeda Pharmaceuticals U.S.A., Inc.
$2,400
Roche Diagnostics Corporation
$2,249
Stryker Corporation
$139
Pacira Pharmaceuticals Incorporated
$128
AMAG Pharmaceuticals, Inc.
$120
Becton, Dickinson and Company
$105
Medtronic, Inc.
$94
Lilly USA, LLC
$89
Amgen Inc.
$84
Bayer HealthCare Pharmaceuticals Inc.
$60
Helsinn Therapeutics (U.S.), Inc.
$44
Celgene Corporation
$43
Regeneron Pharmaceuticals, Inc.
$38
Seattle Genetics, Inc.
$34
Smith+Nephew, Inc.
$34
BeiGene USA, Inc.
$33
Regeneron Healthcare Solutions, Inc.
$26
Novartis Pharmaceuticals Corporation
$25
MILLICENT US INC
$21
Hologic, LLC
$17
GENZYME CORPORATION
$15
CooperSurgical, Inc.
$11
Top 3 companies account for 65.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ARISTA AH FLEXITIP · Aliqopa · Aranesp · Avastin · BOSULIF · BRUKINSA · CINVANTI · Da Vinci Surgical System · Doptelet · ELAHERE · ENHERTU · Elahere · Epkinly · FEMRING · FLOSEAL · INTELLIS ADAPTIVESTIM · INTRAROSA · Iovera · JEMPERLI · KEYTRUDA · LIBTAYO · LYNPARZA · Lenvima · MD cobas Instruments and Reagents · MVASI · MYCHOICE CDX · MYRISK · Monoferric · MyoSure · Neulasta · No Related Product · Nplate · Other Gyn Products · PRECISETUMOR · Perjeta · RYDAPT · Rubraca · SPY-PHI SYSTEM · STRAVIX · SUSTOL · TISSEEL · TIVDAK · Tivdak · VENCLEXTA · VERZENIO · VOTRIENT · XPOVIO · Xofigo · ZEJULA · ZYKADIA · myChoice CDx · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gynecologic oncology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for gynecologic oncology physician in CA.

Looking for a gynecologic oncology physician in Los Angeles?
Compare gynecologic oncology physicians in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse gynecologic oncology physicians nearby

Geographic Context

Gynecologic oncology physicians within 10 mi
32
Per 100K population
0.3
County median income
$87,760
Nearest hospital
RONALD REAGAN UCLA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chase is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 0% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chase experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Chase performed 40 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chase receive payments from pharmaceutical companies?
Yes. Dr. Chase received a total of $1,226,552 from 47 companies across 969 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chase's costs compare to other gynecologic oncology physicians in Los Angeles?
Dr. Chase's average Medicare payment per service is $125. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chase) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →